Iovance Biotherapeutics Inc. buy Wells Fargo & Company
Start price
30.05.23
/
50%
€7.97
Target price
30.05.24
€15.85
Performance (%)
4.72%
End price
31.05.24
€8.35
Summary
This prediction ended on 31.05.24 with a price of €8.35. With a performance of 4.72%, the BUY prediction by Wells_Fargo___Compan for Iovance Biotherapeutics Inc. closed with a slight gain. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Iovance Biotherapeutics Inc. | 10.830% | 10.830% | 182.299% | 6.376% |
| iShares Core DAX® | -0,05 % | 5,96 % | 7,40 % | 65,85 % |
| iShares Nasdaq 100 | 0,92 % | 3,69 % | 28,14 % | 93,30 % |
| iShares Nikkei 225® | 3,01 % | 6,64 % | 48,89 % | 89,08 % |
| iShares S&P 500 | -0,36 % | 2,75 % | 22,53 % | 71,94 % |
Comments by Wells_Fargo___Compan for this prediction
In the thread Iovance Biotherapeutics Inc. diskutieren
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $17.00 price target on the stock, up previously from $11.00.
Ratings data for IOVA provided by MarketBeat
In the thread Trading Iovance Biotherapeutics Inc.
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Wells_Fargo___Compan for Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€1.87
08.08.25
08.08.25
€12.01
08.08.26
08.08.26
188.48%
09.08.26
09.08.26
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€11.70
20.02.24
20.02.24
€20.35
20.02.25
20.02.25
-52.82%
21.02.25
21.02.25